Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Allan Steven Jacobson

Director at Ptc Therapeutics, Inc. (PTCT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.9M

Reported trades

Filed Stock Type Shares Price Value Since
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 5,70117,451 held (−25%) $80.13 $457K -19.3%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 6,10017,451 held (−26%) $80.15 $489K -19.3%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 2,26421,486 held (−10%) $82.63 $187K -21.7%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 2,51018,976 held (−12%) $83.93 $211K -22.9%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 1,12517,851 held (−6%) $84.45 $95K -23.4%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 40017,451 held (−2%) $85.24 $34K -24.1%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 2,46022,891 held (−10%) $82.58 $203K -21.7%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 3,50219,389 held (−15%) $83.38 $292K -22.4%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 1,23818,151 held (−6%) $84.47 $105K -23.4%
Nov 26SEC PTCTPtc Therapeutics, Inc. Sell Plan 70017,451 held (−4%) $85.32 $60K -24.2%
Oct 7SEC PTCTPtc Therapeutics, Inc. Sell Plan 12,00017,451 held (−41%) $65.00 $780K -0.5%
  • Sell

    Director Allan Steven Jacobson sold $457K of PTCT at $80.13 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Allan Steven Jacobson sold $489K of PTCT at $80.15 — cuts the stake by 26%; pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Allan Steven Jacobson sold $187K of PTCT at $82.63 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Allan Steven Jacobson sold $211K of PTCT at $83.93 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Allan Steven Jacobson sold $95K of PTCT at $84.45 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Allan Steven Jacobson sold $34K of PTCT at $85.24 — pre-scheduled 10b5-1 plan sale.